UROMEMS
UroMems is innovative per se and focuses on clearly identified clinical needs, for their prevalence, but also for their negative impact on patients’ quality of life.
UROMEMS
Social Links:
Industry:
Health Care Medical Medical Device
Founded:
2011-01-01
Address:
Grenoble, Rhone-Alpes, France
Country:
France
Website Url:
http://www.uromems.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
81 M EUR
Technology used in webpage:
Content Delivery Network Amazon SSL By Default HSTS Java EE OVH Express Algolia Apollo GraphQL Rocket Chat
Similar Organizations
Alignment Health
Alignment Health provides eldercare services.
Creative Biosciences
Creative Biosciences is a biomedical technology company.
Demant Technology Centre
Demant Technology Centre is an innovative R & D company.
FineHeart
FineHeart is a medical device company
FloBio
FloBio develops point-of-care diagnostics for bleeding risk based on real-time blood analysis.
HeartVista
HeartVista is a medical technology company.
OpenTeleHealth
OpenTelehealth is a universal cloud-based remote patient monitoring platform.
Osciflex
Osciflex system imitates nature’s process to prevent deadly blood clots.
Proteon Pharmaceuticals
Proteon Pharmaceuticals is an innovative biotech company.
SyMap Medical
SyMap Medical is an innovative medical device company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Crédit Mutuel Innovation
Crédit Mutuel Innovation investment in Series C - UroMems
Arbevel
Arbevel investment in Series C - UroMems
Hil-Invent
Hil-Invent investment in Series C - UroMems
Bpifrance
Bpifrance investment in Series C - UroMems
b2venture
b2venture investment in Series C - UroMems
European Innovation Council
European Innovation Council investment in Series C - UroMems
Wellington Partners
Wellington Partners investment in Series C - UroMems
Supernova Invest
Supernova Invest investment in Series C - UroMems
Wellington Partners
Wellington Partners investment in Series B - UroMems
Arbevel
Arbevel investment in Series B - UroMems
Official Site Inspections
http://www.uromems.com Semrush global rank: 10.32 M Semrush visits lastest month: 234
Unable to get host informations!!!
More informations about "UroMems"
UroMems - Home
Our story Co-founded in 2011 by renowned and award-winning smart medical device serial entrepreneur, biomedical engineer and practicing urologist who hold multiple patents, UroMems is a global company pioneering breakthrough technology for … See details»
UroMems - Crunchbase Company Profile & Funding
UroMems is an innovative medtech company.Where is UroMems's headquarters? UroMems is located in Grenoble, Rhone-Alpes, France. Who invested in … See details»
UroMems 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for UroMems. Use the PitchBook Platform to explore the full profile. See details»
UroMems Company Profile - Office Locations, Competitors ... - Craft
UroMems $32.57 m in total funding,. See insights on UroMems including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. See details»
UroMems (FR) - life-sciences-france.com
Jan 1, 2011 UroMems, founded in 2011, focuses on the design, development and marketing of active implantable medical devices for the treatment of severe stress urinary incontinence. At … See details»
UroMems Initiates First-in-Human Study of Its Smart Implant to Treat ...
Nov 29, 2022 UroMems, a global company developing breakthrough, mechatronics technology to treat stress urinary incontinence (SUI), announced today that it has successfully completed the … See details»
UroMems | Crédit Mutuel Innovation
Jul 2, 2024 Under the strong and steady leadership, energy and guidance of co-founders Chief Executive Officer Hamid Lamraoui and Chief Medical Officer Professor Pierre Mozer, UroMems … See details»
UroMems Raises Record $47 million (€44 Million) in Series C …
Jun 25, 2024 UroMems, a global company developing innovative, implantable mechatronics technology to treat stress urinary incontinence (SUI), today announced it has raised $47 million in … See details»
UroMems - Company
UroMems was founded in 2011 and focuses on designing, developing and commercializing active implantable medical devices. The company is based at the heart of the French Alps, in the city of Grenoble, representing one of the most … See details»
UroMems Appoints Former Axonics Executive Rinda Sama to Board …
UroMems has successfully achieved critical milestones in research and development, clinical outcomes and building the organization, including recently securing $47 million in funding on the … See details»
UroMems Raises Record $47 million (€44 Million) in Series C …
Jun 27, 2024 UroMems, a global company developing innovative, implantable mechatronics technology to treat stress urinary incontinence (SUI), today announced it has raised $47 million in … See details»
UroMems | Crédit Mutuel Equity
Jul 2, 2024 Under the strong and steady leadership, energy and guidance of co-founders Chief Executive Officer Hamid Lamraoui and Chief Medical Officer Professor Pierre Mozer, UroMems … See details»
UroMems Announces Successful Results in First-Ever Female Clinical ...
Feb 20, 2025 UroMems has successfully achieved critical milestones in research and development, clinical outcomes and building the organization, including recently securing $47 million in funding … See details»
UroMems awarded FDA IDE to use artificial urinary sphincter in …
1 day ago UroMems is set to enter the pivotal trial phase with its device for treating stress urinary incontinence (SUI). The company was awarded an investigational device exemption (IDE) from … See details»
UroMems
UroMems aims at revolutionizing the treatment of severe stress urinary incontinence with smart active implants, using the latest technological advances in the field of embedded systems and … See details»
UroMems Announces Successful Results in First-Ever Female Clinical ...
Feb 20, 2025 UroMems has successfully achieved critical milestones in research and development, clinical outcomes and building the organization, including recently securing $47 million in funding … See details»
UroMems Raises $47M for Implant to Treat Stress Urinary Incontinence
Jun 25, 2024 UroMems has surpassed milestones in research and development, clinical outcomes and building the organization. The funding comes on the heels of strong results from the first-in … See details»
UroMems
UroMems has successfully achieved critical milestones in research and development, clinical outcomes and building the organization, including recently securing $47 million in funding on the … See details»
UroMems
Under the strong and steady leadership, energy and guidance of co-founders Chief Executive Officer Hamid Lamraoui and Chief Medical Officer Professor Pierre Mozer, UroMems has successfully … See details»
UroMems
GRENOBLE, France and MINNEAPOLIS, Feb. 20, 2025 /PRNewswire/ - UroMems, a global company developing innovative, mechatronics technology to treat stress urinary incontinence … See details»